(Q52583504)

4 May 2018

title

The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. (English)

1 reference

4 May 2018

1 reference

12

Janusz Rak

1 reference

4 May 2018

author name string

Chloe Milsom

1

1 reference

4 May 2018

Joanne Yu

2

1 reference

4 May 2018

Linda May

3

1 reference

4 May 2018

Brian Meehan

4

1 reference

4 May 2018

Nathalie Magnus

5

1 reference

4 May 2018

Khalid Al-Nedawi

6

1 reference

4 May 2018

Jim Luyendyk

7

1 reference

4 May 2018

Jefferey Weitz

8

1 reference

4 May 2018

Petr Klement

9

1 reference

4 May 2018

George Broze

10

1 reference

4 May 2018

Nigel Mackman

11

1 reference

4 May 2018

publication date

1 January 2007

1 reference

4 May 2018

published in

Thrombosis Research

1 reference

4 May 2018

volume

120 Suppl 2

1 reference

4 May 2018

page(s)

S82-91

1 reference

4 May 2018

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Thrombophilia in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

The effect of low molecular weight heparin on survival in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Emerging insights in tissue factor-dependent signaling events.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor, thrombin, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Mechanisms of disease: the impact of antithrombotic therapy in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Hypercoagulability preceding cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Plasminogen activation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Angiogenesis and proteins of the hemostatic system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

The hemostatic system as a regulator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

The heparins and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Mechanisms of cancer-induced thrombosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor and angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Blood-borne tissue factor: another view of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue-specific hemostasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Protease-activated receptors: contribution to physiology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Role of tissue factor in hemostasis, thrombosis, and vascular development

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Thrombin signalling and protease-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Protease-activated receptors in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Role and regulation of the thrombin receptor (PAR-1) in human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Thrombin receptor expression is upregulated in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

The hemostatic system and angiogenesis in malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor expression correlates with histological grade in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

The coagulation system as a target for the treatment of human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Effect of antihemostatic agents on experimental tumor dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Microvesicle-associated tissue factor and Trousseau's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

A functional role for hemostasis in early cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Effect of tissue factor deficiency on mouse and tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Regulation of tissue factor and angiogenesis-related genes by changes in cell shape

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Roots and stems: stem cells in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

The road ended up at stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

A perivascular niche for brain tumor stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Beyond tumorigenesis: cancer stem cells in metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor and tumor: clinical and laboratory aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Role of tissue factor in embryonic blood vessel development.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Regulation of angiogenesis by tissue factor cytoplasmic domain signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Low levels of tissue factor are compatible with development and hemostasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Procoagulant microparticles: disrupting the vascular homeostasis equation?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

Tissue factor in cancer angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970135-4

7 January 2021

10.1016/S0049-3848(07)70135-4

Identifiers

DOI

1 reference

4 May 2018

PubMed ID

18023719

1 reference

4 May 2018